BioSyent Inc.
RX
Rank in Stocks
#18141
BioSyent Inc., together with its subsidiaries, acquires or licenses, develops,... BioSyent Inc., together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia. It offers Tibella, a hormone replacement therapy consisting of tibolone; Inofolic, a natural health product to address polycystic ovarian syndrome symptoms; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by aging, menopause, stress, and chemotherapy; and Gelclair, a gel formulated to aid the pain or oral mucositis. In addition, the company provides Cathejell, a lubricant with anesthetic with the indication of lubricating and opening the urethra before the insertion of the catheter; and Proktis-M, a rectal suppository for the healing of the anus and rectum. The company sells its products through wholesalers and retail pharmacy chains. BioSyent Inc. was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006. The company was incorporated in 2006 and is headquartered in Mississauga, Canada.
Share Price
$12.68
Last synced: 2026-11-09
Market Cap
$143.35M
Change (1 day)
1.02%
Change (1 year)
63.94%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade BioSyent Inc. (RX)
Category
Healthcare
Dividend history for BioSyent Inc. (RX)
BioSyent Inc. (stock symbol: RX) made a total of 16 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $0.54
Dividend yield (TTM) : 1.26%
The sum of all dividends (adjusted for stock splits) is : $0.54
Dividend yield (TTM) : 1.26%
Dividend payments for BioSyent Inc. (RX) from 2022 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| 2026 (TTM) | $0.16 | 8.77% |
| 2025 | $0.14 | 8.78% |
| 2024 | $0.13 | 11.27% |
| 2023 | $0.12 | 301.59% |
| 2022 | $0.0294 | 0.00% |
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| 2026 (TTM) | $0.16 | 8.77% |
| 2025 | $0.14 | 8.78% |
| 2024 | $0.13 | 11.27% |
| 2023 | $0.12 | 301.59% |
| 2022 | $0.0294 | 0.00% |
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 26.00% |
US
|
|
| 0.00% |
SE
|
|
| 21.00% |
FR
|
|
| 71.00% |
HK
|
|
| 47.00% |
IT
|
Questions about BioSyent Inc.'s dividend per share
What is BioSyent Inc.'s dividend per share?
BioSyent Inc.'s dividend per share over the last twelve months is $0.16, as of Aug 2026.
What was BioSyent Inc.'s dividend per share in 2025?
In 2025, BioSyent Inc.'s dividend per share was $0.14, 8.78% more than in 2024 ($0.13).
How has BioSyent Inc.'s dividend per share changed since 2022?
From 2022 to 2025, BioSyent Inc.'s dividend per share went from $0.03 to $0.14, an average growth of 69.39% a year.